A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Pergolide
Ivacaftor
The serum concentration of Bosutinib can be increased when it is combined with Ivacaftor.
Pergolide
Ticagrelor
The serum concentration of Bosutinib can be increased when it is combined with Ticagrelor.
Pergolide
Brefeldin A
The serum concentration of Bosutinib can be increased when it is combined with Brefeldin A.
Pergolide
Isavuconazonium
The serum concentration of Bosutinib can be increased when it is combined with Isavuconazonium.
Pergolide
Carfilzomib
The serum concentration of Carfilzomib can be increased when it is combined with Bosutinib.
Pergolide
Armodafinil
The metabolism of Bosutinib can be increased when combined with Armodafinil.
Pergolide
Methoxy polyethylene glycol-epoetin beta
The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Bosutinib.
Pergolide
Peginesatide
The risk or severity of Thrombosis can be increased when Peginesatide is combined with Bosutinib.
Pergolide
Sipuleucel-T
The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Bosutinib.
Pergolide
Roflumilast
Roflumilast may increase the immunosuppressive activities of Bosutinib.
Pergolide
Tetrandrine
The risk or severity of adverse effects can be increased when Bosutinib is combined with Tetrandrine.
Pergolide
Bleselumab
The risk or severity of adverse effects can be increased when Bosutinib is combined with Bleselumab.
Pergolide
Rozanolixizumab
The risk or severity of adverse effects can be increased when Bosutinib is combined with Rozanolixizumab.
Pergolide
Risankizumab
The risk or severity of adverse effects can be increased when Bosutinib is combined with Risankizumab.
Pergolide
Monomethyl fumarate
The risk or severity of adverse effects can be increased when Bosutinib is combined with Monomethyl fumarate.
Pergolide
Fluclorolone
The risk or severity of adverse effects can be increased when Bosutinib is combined with Fluclorolone.
Pergolide
Fluperolone
The risk or severity of adverse effects can be increased when Bosutinib is combined with Fluperolone.
Pergolide
Begelomab
The risk or severity of adverse effects can be increased when Bosutinib is combined with Begelomab.
Pergolide
Fluocortin
The risk or severity of adverse effects can be increased when Bosutinib is combined with Fluocortin.
Pergolide
9-(N-methyl-L-isoleucine)-cyclosporin A
The risk or severity of adverse effects can be increased when Bosutinib is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3